INS and metabolic syndrome: Other emerging evidence is also likely to influence screening decisions, such as calls for age-specific HbA1c reference intervals [29] and adding insulin tests for prediabetes screening, particularly for younger people and those at risk of metabolic syndrome [13–15, 30].